KEVIN C OBOYLE Insider Trading $GNMK GenMark Diagnostics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KEVIN C OBOYLE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KEVIN C OBOYLE. KEVIN C OBOYLE is CFO and Executive VP in NUVASIVE INC ($NUVA) and VP, Finance and CFO in NUVASIVE INC ($NUVA) and Director in Zeltiq Aesthetics Inc ($ZLTQ) and Director in NEVRO CORP ($NVRO) and Director in GenMark Diagnostics, Inc. ($GNMK) and Director in Wright Medical Group N.V. ($TRNX) and Director in Sientra, Inc. ($SIEN).
KEVIN C OBOYLE in GenMark Diagnostics, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of KEVIN C OBOYLE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 22 2021
$GNMK Market Capitalization: $508.12M
$GNMK Previous Close: $11.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KEVIN C OBOYLE in GenMark Diagnostics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, GNMK, NVRO, NUVA, SIEN, TRNX, ZLTQ
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 22 2021 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | D | 4.38 | 13,426 | 58,806 | 0 | |
| Apr 22 2021 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | U | 24.05 | 131,678 | 3,166,856 | 0 | 131.7 K to 0 (-100.00 %) |
| Feb 19 2021 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 10,130 | 0 | 131,678 | 121.5 K to 131.7 K (+8.33 %) |
| Jun 02 2020 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 17,998 | 0 | 121,548 | 103.6 K to 121.5 K (+17.38 %) |
| Mar 09 2020 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | P | 4.53 | 10,800 | 48,924 | 103,550 | 92.8 K to 103.6 K (+11.64 %) |
| Feb 27 2020 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 3,973 | 0 | 92,750 | 88.8 K to 92.8 K (+4.48 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.00 | 18,050 | 108,300 | 0 | |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Option Exercise | M | 6.00 | 25,000 | 150,000 | 0 | |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 6.42 | 16,870 | 108,305 | 88,777 | 105.6 K to 88.8 K (-15.97 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Payment of Exercise | F | 6.42 | 23,365 | 150,003 | 105,647 | 129 K to 105.6 K (-18.11 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | M | 6.00 | 18,050 | 108,300 | 129,012 | 111 K to 129 K (+16.27 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | M | 6.00 | 25,000 | 150,000 | 110,962 | 86 K to 111 K (+29.08 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | S | 6.51 | 16,150 | 105,137 | 85,962 | 102.1 K to 86 K (-15.82 %) |
| Aug 19 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Sell | S | 6.51 | 2,200 | 14,322 | 102,112 | 104.3 K to 102.1 K (-2.11 %) |
| Jun 04 2019 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 19,851 | 0 | 104,312 | 84.5 K to 104.3 K (+23.50 %) |
| May 29 2018 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 18,866 | 0 | 84,461 | 65.6 K to 84.5 K (+28.76 %) |
| May 30 2017 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 7,832 | 0 | 65,595 | 57.8 K to 65.6 K (+13.56 %) |
| May 31 2016 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 9,965 | 0 | 57,763 | 47.8 K to 57.8 K (+20.85 %) |
| Nov 04 2015 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Buy | P | 6.71 | 4,500 | 30,195 | 47,798 | 43.3 K to 47.8 K (+10.39 %) |
| Jun 01 2015 | GNMK | GenMark Diagnostic ... | OBOYLE KEVIN C | Director | Grant | A | 0.00 | 7,604 | 0 | 43,298 | 35.7 K to 43.3 K (+21.30 %) |
Page: 1